Bactana drug to combat diabetes in pets
Entrepreneur John Kallassy founded Bactana in May 2017. The company has been part of UConn’s Technology Incubation Program since 2019, operating out of lab space in...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
Entrepreneur John Kallassy founded Bactana in May 2017. The company has been part of UConn’s Technology Incubation Program since 2019, operating out of lab space in...
Writing in the CT Mirror, Dawn Hocevar, President and CEO of BioCT, urges the Connecticut legislature and Gov. Ned Lamont to take a long hard look at...
A significant amount of human genetic material turns out to be long, repetitive sections. Although every human has some repeats, not everyone has the same...
View this email in your browser Weekly Roundup – March 31, 2022 The...
Unabated glucose production from the liver is one of the key mechanisms of diabetes. Through better understanding how metformin works to suppress gluconeogenesis, Yale researchers hope to...
Artizan Biosciences reports that the U.S. Patent and Trademark Office has issued a patent that broadens the use of the company’s proprietary IgA-SEQ™ discovery platform. Artizan’s...
View this email in your browser Career News – March 29, 2022 Alphina Therapeutics Research Associate/Associate Scientist/Sr. Associate Scientist/Scientist, Biochemistry New Haven Ancera Senior Development Engineer...
Scientists at Yale’s Microbial Sciences Institute have taken an important step in our understanding of how infection alters proteins in a way that promotes tumor growth. The...
Top UConn leaders want to spend $46 million to hire ten new research, innovation and entrepreneurship faculty and provide them new lab space and equipment, as...
Quasi-public venture capital firm Connecticut Innovations invested $15.1 million in 47 deals during the last quarter of 2021, the New Haven-based company reports. Of that sum,...